Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

The treatment might help COVID-19 related hair loss, but more research is needed.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

Testosterone may influence COVID-19 severity and outcomes.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Many displaced schoolchildren in Cameroon are malnourished, with high rates of thinness, stunting, underweight, and deficiencies in iron and protein.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Chronic scalp lesions with crusts and pus that heal with strong topical steroids suggest Erosive Pustular Dermatosis, confirmed by biopsy showing specific immune cells.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Skin can become dry and thick in hypothyroidism.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

The patient was diagnosed with anorexia nervosa and severe malnutrition, requiring urgent refeeding and monitoring.